335059-94-4

Basic information

• Product Name: CarbaMic acid, N-[2-[[(4-chlorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester
• Synonyms: CarbaMic acid, N-[2-[[(4-chlorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester;tert-Butyl (2-((4-chlorobenzyl)aMino)ethyl)carbaMate;tert-Butyl N-[2-[(4-chlorophenyl)methylamino]ethyl]carbamate
• CAS NO: 335059-94-4
• Molecular Formula: C₁₄H₂₁ClN₂O₂
• Molecular Weight: 284.78174
• Mol File: 335059-94-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: CarbaMic acid, N-[2-[[(4-chlorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: CarbaMic acid, N-[2-[[(4-chlorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester(335059-94-4)
• EPA Substance Registry System: CarbaMic acid, N-[2-[[(4-chlorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester(335059-94-4)

Safety Data

• Hazardous Substances Data: 335059-94-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
CarbaMic acid, N-[2-[[(4-chlorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester is used as a pharmaceutical intermediate for the development and formulation of various drugs. Its unique chemical structure allows it to be a key component in the synthesis of active pharmaceutical ingredients.
Used in Research and Development:
This chemical compound is also used in research and development for pharmaceutical products. Its potential applications in drug discovery and development make it a valuable tool for scientists and researchers working in the field of pharmaceuticals.
It is important to handle and use CarbaMic acid, N-[2-[[(4-chlorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester with care and in accordance with safety procedures to minimize any potential health and environmental risks.

Upstream product

• 57260-73-8 N-BOC-1,2-diaminoethane 
• 104-88-1 4-chlorobenzaldehyde 
• 215654-54-9 C₁₄H₁₉ClN₂O₂ 
• 104-83-6 1-Chloro-4-(chloromethyl)benzene 

Downstream Products

• 60927-95-9 1-(4-chlorobenzyl)imidazolidin-2-one 
• 853686-95-0 N-(2-amino-ethyl)-N-(4-chlorobenzyl)-4-pyridin-4-yl-benzamide 
• 1097834-07-5 benzyl 4-((2-(tert-butoxycarbonylamino)ethyl)(4-chlorobenzyl)carbamoyl)piperazine-1-carboxylate 
• 853680-69-0 {2-[(4-chlorobenzyl)-(4-pyridin-4-yl-benzoyl)-amino]-ethyl}-carbamic acid tert-butyl ester 
• 335059-97-7 {2-[(2-amino-4-methyl-pentanoyl)-(4-chloro-benzyl)-amino]-ethyl}-carbamic acid tert-butyl ester 

Relevant articles and documents

Inhibitory effect of novel tetrahydropyrimidine-2(1H)-thiones on melanogenesis

The series of imidazoldine-2-thiones 2 and tetrahydropyrimidine-2-thiones 3 were discovered as inhibitor of α-MSH-induced melanin production in melanoma B16 cells. The primary bioassay showed that 1-(4-ethylbenzyl)-tetrahydropyrimidine-2(1H)-thione 3e (>1

PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invent

SUBSTITUTED 4-BENZYLOXY-BENZOIC ACID AMIDE DERIVATIVES

The present invention relates to novel substituted 4-benzyloxy-benzoic acid amide derivatives, processes for their preparation, and their use in medicaments, especially for the prophylaxis and treatment of diseases associated with Cold Menthol Receptor 1 (CMR-1) activity, in particular for the treatment of urological diseases or disorders, such as detrusor overactivity (overactive bladder), urinary incontinence, neurogenic detrusor overactivity (detrusor hyperflexia), idiopathic detrusor overactivity (detrusor instability), benign prostatic hyperplasia, and lower urinary tract symptoms; chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, and inflammatory disorders such as asthma and chronic obstructive pulmonary (or airways) disease (COPD).

SUBSTITUTED 2-BENZYLOXY-BENZOIC ACID AMIDE DERIVATIVES TECHNICAL FIELD OF THE INVENTION

The present invention relates to novel substituted 2-benzyloxy-benzoic acid amide derivatives, processes for their preparation, and their use in medicaments, especially for the prophylaxis and treatment of diseases associated with Cold Menthol Receptor 1

AKT PROTEIN KINASE INHIBITORS

The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.

Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor

Arylalkylidene rhodanines 2(a-d) inhibit HCV NS3 protease at moderate concentrations. They are better inhibitors of other serine proteases such as chymotrypsin and plasmin. However, the selectivity of arylmethylidene rhodanines (8a, 9a) with bulkier and more hydrophobic functional groups increases by 13- and 25-fold towards HCV NS3 protease respectively.